First drug to slow Alzheimer's progression approved in US | 5 points
US officials have granted full approval to Alzheimer's drug Leqembi, the first medicine shown to slow cognitive decline caused by the disease. | World News
Stay updated with breaking news from Full Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US officials have granted full approval to Alzheimer's drug Leqembi, the first medicine shown to slow cognitive decline caused by the disease. | World News
The US drug regulator approves Leqembi, a new Alzheimer's medicine, making it more accessible through government-run health insurance.
The FDA approves Pfizer’s oral COVID-19 drug; hundreds of thousands of people lose Medicaid coverage after pandemic protections expire; irregular menstrual cycles seem to be linked with higher cardiovascular disease (CVD) risks.
The Scottish cereals lists include varieties of spring and winter barley, wheat and oats that are of most agronomic and commercial value to Scottish…
The ups and downs of the COVID-19 pandemic are taking a slight upswing in New York following a downward trend in new infections.